Australia markets closed

Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
1.8800+0.0200 (+1.08%)
At close: 03:04PM CST
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
28,153,619
26,309,323
23,250,296
26,857,149
-
Other short-term investments
1,798,411
2,082,502
2,907,532
3,391,628
-
Total cash
29,952,030
28,391,826
26,157,829
30,248,777
-
Net receivables
77,197
82,684
28,744
15,932
-
Inventory
4,131,949
10,504,019
10,224,465
10,716,158
-
Other current assets
-
-
-3,796,016
-4,291,509
-3,729,822
Total current assets
50,665,931
55,977,586
50,358,426
51,743,051
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,461,631
979,685
927,549
726,402
-
Accumulated depreciation
-171,054
-135,619
-97,222
-67,555
-
Net property, plant and equipment
1,290,577
844,066
830,328
658,847
-
Equity and other investments
-
-
13,020,384
12,217,841
12,396,061
Goodwill
6,192,539
6,192,211
6,192,211
6,192,211
-
Intangible assets
283,200
299,340
269,706
189,999
-
Other long-term assets
5,538,903
6,046,732
8,406,697
6,238,142
-
Total non-current assets
251,269,999
232,621,104
213,545,540
187,728,894
-
Total assets
301,935,930
288,598,690
263,903,966
239,471,945
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
18,248,100
21,189,583
9,425,768
4,583,818
-
Accounts payable
949,045
206,898
93,511
35,012
-
Other current liabilities
45,981
231,461
258,540
52,005
-
Total current liabilities
24,462,097
24,985,753
13,059,854
8,016,359
-
Non-current liabilities
Long-term debt
7,099,220
6,788,309
6,092,440
2,760,300
-
Deferred tax liabilities
1,378,201
1,347,660
1,280,968
1,519,339
-
Other long-term liabilities
55,714,365
57,516,444
51,103,148
45,442,599
-
Total non-current liabilities
243,840,080
229,010,026
213,369,433
196,867,666
-
Total liabilities
268,302,177
253,995,779
226,429,287
204,884,025
-
Stockholders' equity
Common stock
4,940,629
4,940,629
4,940,629
4,940,629
-
Retained earnings
5,310,046
6,508,547
6,327,444
5,909,385
-
Total stockholders' equity
20,590,056
21,411,956
22,553,334
21,134,912
-
Total liabilities and stockholders' equity
301,935,930
288,598,690
263,903,966
239,471,945
-